Bill > HB1984

This bill expands the ability of certain healthcare providers to directly administer buprenorphine, a medication used to treat opioid use disorder, either on its own (mono product) or without naloxone, which is an opioid overdose reversal medication. It clarifies that prescribing buprenorphine to a nursing mother or prescribing an injectable form of buprenorphine does not prevent these healthcare providers from prescribing buprenorphine without naloxone for opioid use disorder treatment. The bill amends existing Tennessee law to allow for these expanded uses, with the intention of improving access to treatment for individuals struggling with opioid addiction.